Financials
- Market Capitalization 588.83 M
- Employee 1 315
- Founded 2011
- CEO Ming Hsieh
- Website www.fulgentgenetics.com
- Headquarter Delaware, United States
- FIGI BBG00DR7LTG2
- Industry Diagnóstico y pruebas
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-13.36
Relación precio/flujo de caja
2.51
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2364 | OPK Opko Health, Inc. - Common Stock | 1.38 USD | 0.00% | -12.10% | -13.21% | -9.80% | 1.03 B USD | ||
| 2391 | CSTL Castle Biosciences, Inc. - Common stock | 32.69 USD | -5.03% | -8.10% | +1.21% | +32.81% | 998.66 M USD | ||
| 2801 | ACRS Aclaris Therapeutics, Inc. - Common Stock | 3.60 USD | -6.01% | -15.69% | -32.08% | +88.48% | 529.92 M USD | ||
| 2998 | MYGN Myriad Genetics, Inc. - Common Stock | 4.26 USD | -1.16% | -3.84% | +24.56% | -48.49% | 407.47 M USD |